GGrantIndex
Sort

11,323 grants matching glioblastoma

Examining the role of XRN2 in radio and chemo-resistance

$216,873
Julio Cesar Morales · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2019 · GM

ANTI-PDZ DOMAIN ANTIBODIES ENHANCE THE EFFICACY OF RADIOTHERAPY

$216,853
Sriram Devanathan · Medical Guidance Systems, Llc · R43 · FY2016 · CA

Role of RBBP4/p300 Complex in Recovery from therapy induced DNA damage in glioblastoma

$216,739
Gaspar Julius Kitange · University Of Minnesota · R01 · FY2021 · CA

Core 2: Biocomputational and Biostatistics Core

$216,382
Donna S. Neuberg · Brigham And Women'S Hospital · P01 · FY2021 · CA

Phosphoinositide Regulation of Focal Adhesion Structure

$216,260
Oregon State University · R01 · FY2003 · GM

Examining the role of XRN2 in radio and chemo-resistance

$216,226
Julio Cesar Morales · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2020 · GM

Clinical Trials and Imaging Core

$216,181
Annick Desjardins · Duke University · P01 · FY2020 · CA

Phosphoinositide Regulation of Focal Adhesion Structure

$216,107
Oregon State University · R01 · FY2004 · GM

Chemoprotection & Immune Remodeling after Hematopoietic Progenitor Cell Gene Therapy for Glioblastoma

$216,036
Stanton L Gerson · Case Western Reserve University · U01 · FY2022 · CA

Regulation of glioblastoma cells by GABAergic neurons in human organoid-tumor chimeras

$215,811
Oleksandr Shcheglovitov · University Of Utah · R21 · FY2023 · CA

Exploratory Phase I/II Clinical Studies to Improve the Therapeutic Ratio of

$215,805
Helen A Shih · Massachusetts General Hospital · U19 · FY2014 · CA

Molecular Profiling and Bioinformatics

$215,705
Michael E. Berens · Beckman Research Institute/City Of Hope · U19 · FY2024 · CA

Targeting Cysteine Susceptibility in Glioblastoma

$215,684
Evan K. Noch · Ut Southwestern Medical Center · K08 · FY2024 · NS

Targeting Cysteine Susceptibility in Glioblastoma

$215,684
Evan K. Noch · Ut Southwestern Medical Center · K08 · FY2025 · NS

Analysis of Migration Associated Treatment Resistance in Glioblastoma to Identify Novel Therapeutics

$215,606
James Battiste · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2019 · GM

Development of an Adenoviral Vector with Chimeric Fiber for Malignant Glioma

$215,325
Maciej S Lesniak · University Of Chicago · R21 · FY2008 · CA

Generation of TWIST1 reporters through characterization of TWIST1 dependent netwo

$215,325
Andrei M Mikheev · University Of Washington · R21 · FY2014 · NS

Discovery of PPI inhibitors for the FAK FAT domain

$215,284
Timothy A Marlowe · University Of Arizona · R21 · FY2023 · CA

Profiling and targeting micro-RNA expression during oncolytic virotherapy

$215,226
Hiroaki Wakimoto · Massachusetts General Hospital · R21 · FY2010 · NS

DESIGN OF GENETICALLY ENGINEERED HSV FOR CANCER THERAPY

$215,218
University Of Alabama At Birmingham · P01 · FY2000 · CA

PET Imaging Agents for Protoporphyrin IX

$215,101
Mark Myron Goodman · Emory University · R21 · FY2022 · CA

INVESTIGATION OF LIPID METABOLISM REVEALS NOVEL VULNERABILITIES TO FERROPTOSIS IN GLIOBLASTOMA

$215,084
University Of California, Los Angeles · · FY2020 · Department of the Army

Regulation of Microtubule Dynamics and Organization During Cell Division

$214,847
Ryoma Ohi · University Of Michigan At Ann Arbor · R01 · FY2017 · GM

CYTOTOXICITY AND BYSTANDER KILLING FOR HSV-TK SUBSTRATES

$214,833
University Of Michigan At Ann Arbor · R01 · FY2000 · CA

Small Animal Imaging Shared Resource (SAISR)

$214,761
Arion Xenofon Chatziioannou · University Of California Los Angeles · P30 · FY2025 · CA